Search or Ask Iris
Ctrl+K
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Infrastructure stocks rallied after Finance Minister Nirmala Sitharaman announced a record capital expenditure of Rs 12.2 lakh crore for FY27 in the Union Budget 2026.
Choice Institutional Equities maintains its BUY rating on Ambuja Cement with a target price of ₹660, citing ambitious capacity expansion and significant cost-saving measures.
Finance Minister Nirmala Sitharaman's Union Budget 2026 introduces a six-point roadmap focusing on manufacturing, infrastructure, and financial sector reforms to sustain India's economic growth.
The Union Budget 2026 allocates ₹10,000 crore to a new scheme aimed at boosting domestic container manufacturing and reducing India's reliance on imports.
Indian equity benchmarks Sensex and Nifty erased early gains, succumbing to profit booking and heightened volatility ahead of the Union Budget 2026 presentation by the Finance Minister.
The Union Budget 2026 spurred a market rally, with the Sensex rising over 400 points following major announcements on capital expenditure and electronics manufacturing.
The Union Budget 2026 introduces the 'Biopharma Shakti' initiative, allocating ₹10,000 crore over five years to establish India as a global biopharmaceutical manufacturing hub.
Finance Minister Nirmala Sitharaman's Union Budget 2026 prioritizes economic stability, sustained growth, and structural reforms, maintaining the existing income tax structure for the upcoming fiscal year.
The Union Budget 2026 introduces the Biopharma Shakti initiative, allocating ₹10,000 crore over five years to establish India as a global biopharmaceutical manufacturing hub.
The Union Budget 2026 introduces the Rs 10,000 crore 'Biopharma Shakti' initiative, aiming to make India a global biopharma hub and boosting domestic pharma stocks.
The Nifty India Defence index and related stocks are rallying on strong expectations of increased government spending and new contracts in the upcoming Union Budget 2026.
Finance Minister Nirmala Sitharaman is set to present her record-breaking ninth consecutive Union Budget, focusing on sustained growth, fiscal discipline, and key economic reforms.
Indian defence stocks are gaining momentum as investors anticipate an 8-20% increase in capital expenditure allocation in the upcoming Union Budget 2026, boosting domestic manufacturing.
The Union Budget 2026 is expected to prioritize fiscal discipline, with a significant push for capital expenditure funded by ambitious disinvestment targets amid global economic uncertainty.
Indian defence sector stocks are rallying ahead of the Union Budget 2026, driven by strong expectations of increased government capital outlay and a continued push for local manufacturing.
An analysis of NTPC's share price and financial performance for FY25, detailing a 12.28% rise in net profit and a 5.35% increase in revenue.
